This inventor holds 8 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Propella Therapeutics, Inc., Glaxo Wellcome Inc.. Active years: 1996-2024.
Company Filing History:
Years Active: 1996-2024
Title: The Innovations of Matthew J Sharp
Introduction
Matthew J Sharp is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs for treating hormone-dependent disorders. With a total of 8 patents, his work has the potential to impact the treatment of conditions such as prostate cancer.
Latest Patents
Among his latest patents are formulations for sustained-release abiraterone prodrugs. These formulations are designed for parenteral administration to subjects suffering from sex hormone-dependent benign or malignant disorders, including prostate cancer. His innovative methods and kits also address syndromes due to androgen excess and glucocorticoid excess, such as hypercortisolemia.
Career Highlights
Matthew has worked with prominent companies in the pharmaceutical industry, including Propella Therapeutics, Inc. and Glaxo Wellcome Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Matthew has collaborated with esteemed colleagues such as William R Moore, Jr. and Timothy Mark Willson. These partnerships have fostered an environment of innovation and have led to the advancement of his research.
Conclusion
Matthew J Sharp's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of hormone-dependent disorders.